Tongpeng Xu

6.3k citations
70 papers · 4.9k indexed · 2 hit papers · h-index 35
Topics
Cancer-related molecular mechanisms research (31 papers)RNA modifications and cancer (23 papers)Circular RNAs in diseases (17 papers)
Partner nations
ChinaCanadaGermany

In The Last Decade

Tongpeng Xu

69 papers receiving 4.9k citations

Hit Papers

CircRNAs in cancer metabolism: a review201920262021202320192020100200300

Peers

Tongpeng Xu
Comparison fields: 5 of 95
  • Molecular Biology 4.2k
  • Cancer Research 4.0k
  • Surgery 383
  • Oncology 365
  • Epidemiology 348
Replace Yongqian Shu with:
Yongqian Shu China
Guang-Shun Yang China
Rong‐Quan He China
Bing Chen China
Giulia Romano United States
Yueming Sun China
Keun Hur South Korea
Erbao Zhang China
Cátia Moutinho Spain
Tongpeng Xu relative to Yongqian Shu China Yongqian Shu's profile →
Citations per field
00.5×1.6×
Yongqian Shu · 1×
Citations per year

Countries citing papers authored by Tongpeng Xu

Since Specialization
Citations

This map shows the geographic impact of Tongpeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongpeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongpeng Xu more than expected).

Fields of papers citing papers by Tongpeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongpeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongpeng Xu. The network helps show where Tongpeng Xu may publish in the future.

Co-authorship network of co-authors of Tongpeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Tongpeng Xu. A scholar is included among the top collaborators of Tongpeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongpeng Xu. Tongpeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 2
4 2
5 3
6 7
7 15
8 3
9 24
10 105
11 27
12
CircRNAs in cancer metabolism: a reviewbreakdown →
327
13 76
14 188
15 119
16 141
17 47
18 277
19 261
20 13

About Tongpeng Xu

Tongpeng Xu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 70 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (31 papers), RNA modifications and cancer (23 papers) and Circular RNAs in diseases (17 papers). The work is most often cited by research in Cancer Research (4.0k citations), Molecular Biology (4.2k citations) and Toxicology (47 citations). Tongpeng Xu has collaborated with scholars based in China, Canada and Germany. Frequent co-authors include Rui Xia, Wei De, Erbao Zhang, Ming Sun, Yongqian Shu, Rong Kong, Wenming Chen, Liang Han, Mingde Huang and Dandan Yin. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026